Health platform for heart-kidney-metabolic health
Part of Heart & circulation, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests a smartphone and wearable-based health management platform for people with early-stage cardiovascular-kidney-metabolic (CKM) syndrome. It aims to help patients track and improve their health through personalized support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with CKM stage 0, 1, or 2 (early stages of heart-kidney-metabolic syndrome).
- You can use a smartphone and a wearable activity tracker.
- You are willing to sign a consent form and attend follow-up visits.
- You do not have advanced CKM (stage 3 or 4), a serious illness needing hospitalization, or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who may have a combination of heart disease, kidney problems, or metabolic issues like diabetes or high blood pressure. Researchers hope to learn more about these linked conditions to improve future care.
This study creates a registry to track people who have early signs of heart, kidney, liver, or metabolic health issues. It aims to better understand these conditions and find ways to prevent them from getting worse.
This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.
This study tests whether an AI chatbot on your phone can help you monitor and manage early heart, kidney, and metabolic problems. The goal is to help you stay healthier through regular symptom tracking and self-care tips.
This study follows people with different stages of heart-kidney-metabolic syndrome to understand what factors affect their health over time. It aims to find better ways to predict and manage the condition.
This study tests a program that helps you and your doctor make decisions together to improve your heart, kidney, and metabolic health. You'll use a smartphone app to track your health and get support.
Hear when a new Cardiovascular-kidney-metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.